Effectiveness and safety of infliximab biosimilar CT-P13 in treating ulcerative colitis: a real-life experience in ibd primary centers.
CONCLUSIONS: IFX CT-P13 seems to be very effective and safe at real-life experience in primary IBD centers.
PMID: 28293938 [PubMed - as supplied by publisher]
Source: Minerva Gastroenterologica e Dietologica - Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research
More News: Gastroenterology | Inflammatory Bowel Disease | Nutrition | Remicade | Ulcerative Colitis